NCT04302935

Brief Summary

Full assessment of chronic pain patients based on the ICF-model.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

March 2, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 10, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

March 10, 2020

Status Verified

March 1, 2020

Enrollment Period

12 months

First QC Date

March 2, 2020

Last Update Submit

March 6, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility of a global pain-assessment (i.e. practical use)

    at the time of the assessment: one day (cross-sectional)

Secondary Outcomes (1)

  • norm values for chronic pain patients on all aspects of the global pain-assessment will be reported (i.e. descriptives)

    at the time of the assessment: one day (cross-sectional)

Study Arms (1)

chronic pain patients

Other: Global pain-assessment

Interventions

Global pain-assessment, based on the ICF framework

chronic pain patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with chronic pain.

You may qualify if:

  • Patients with chronic pain for at least 3 months
  • Age =\> 18 years
  • Patient has been informed of the study procedures and has given written informed consent

You may not qualify if:

  • Healthy patients or patients with acute pain.
  • Addiction to drugs, alcohol (\>5 units per day)
  • Evidence of an active disruptive psychiatric disorder that may impact perception of pain, and/or ability to evaluate treatment outcome as determined by investigator
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitair Ziekenhuis Brussel

Jette, Brussels Capital, 1090, Belgium

RECRUITING

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Maarten Moens, prof. dr.

CONTACT

Lisa Goudman, MSc.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
1 Week
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. dr.

Study Record Dates

First Submitted

March 2, 2020

First Posted

March 10, 2020

Study Start

March 2, 2020

Primary Completion

March 1, 2021

Study Completion

March 1, 2021

Last Updated

March 10, 2020

Record last verified: 2020-03

Locations